Viewing Study NCT03596632


Ignite Creation Date: 2025-12-24 @ 9:59 PM
Ignite Modification Date: 2025-12-25 @ 7:36 PM
Study NCT ID: NCT03596632
Status: COMPLETED
Last Update Posted: 2018-12-06
First Post: 2018-07-13
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Study Investigating a Single Oral Dose of Fenebrutinib in Healthy Volunteers
Sponsor: Hoffmann-La Roche
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: GP40605
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators